Publication:
Frequency, Distribution, and Impact on Prognosis of BCR-ABL1 Kinase Domain Mutations in Tyrosine Kinase Inhibitor Resistant Chronic Myelogenous Leukemia Patients

Research Projects

Organizational Units

Journal Issue

Abstract

Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the BCR

Description

Citation

WoS Q

Scopus Q

Q4

Source

Journal of Experimental and Clinical Medicine (Turkey)

Volume

42

Issue

1

Start Page

48

End Page

52

Endorsement

Review

Supplemented By

Referenced By